Michael Kaiser Email & Phone Number

New York, Ny, Us

New York, New York, United States

Evolved investor narrative to be approachable for biotech specialist investors as well as generalists by transforming investor presentation, IR website and creating investor factsheets.Expanded reach of company through grass-roots investor targeting efforts; conducted over 100 one on one meetings with nearly 70 different investors, including 30 new investors. Coached executive team to improve public speaking impact through presentations and meetings. Delivered two R&D investor days… Show more Evolved investor narrative to be approachable for biotech specialist investors as well as generalists by transforming investor presentation, IR website and creating investor factsheets.Expanded reach of company through grass-roots investor targeting efforts; conducted over 100 one on one meetings with nearly 70 different investors, including 30 new investors. Coached executive team to improve public speaking impact through presentations and meetings. Delivered two R&D investor days preparing management and key opinion leaders for scripted remarks, key messaging and question and answer preparation. Participated in attempted wall-crossed financings of $30 million and $60 million; led due diligence planning for potential. Positioned terminated when board of directors took control of CEO and CFO positions. Show less

Hired as Head of IR and quickly assumed all management of end-to-end communications; led a team of two individuals to help transition the story from a preclinical R&D focus to meaningful clinical results. Onboarded two sellside analysts (Chardan Capital Markets and H.C. Wainwright) expanding research coverage and increasing investor access. Following departure of CFO: led attempted wall-crossed financings of $25 million and $40 million; led sale process of SQZ to STEMCELL… Show more Hired as Head of IR and quickly assumed all management of end-to-end communications; led a team of two individuals to help transition the story from a preclinical R&D focus to meaningful clinical results. Onboarded two sellside analysts (Chardan Capital Markets and H.C. Wainwright) expanding research coverage and increasing investor access. Following departure of CFO: led attempted wall-crossed financings of $25 million and $40 million; led sale process of SQZ to STEMCELL Technologies. Show less

Greater New York City Area

Oversaw Business Analytics, Sales Support, Oversight & Supervision of Service Team, and Project Management. Led transformative changes to organization by leveraging business analytics to better align sales, service, operations, and compliance organizations with organizational goals; changes resulted in $1.5 billion net new assets in 1H 2021 compared to $0.5B net new assets in FY 2020. Prominent role during integration planning and operating model development for MS’s acquisition of… Show more Oversaw Business Analytics, Sales Support, Oversight & Supervision of Service Team, and Project Management. Led transformative changes to organization by leveraging business analytics to better align sales, service, operations, and compliance organizations with organizational goals; changes resulted in $1.5 billion net new assets in 1H 2021 compared to $0.5B net new assets in FY 2020. Prominent role during integration planning and operating model development for MS’s acquisition of E*TRADE; ensured smooth integration of the two companies. Show less

Greater New York City Area

Selected by the CEO to help ensure cross-departmental collaboration on key company initiatives including efforts to increase efficiencies within middle- and back-office, streamline and modernize back-end technology and simplify overall customer experiences. Advise executives on long-term strategic planning and corporate development, ultimately positioning the Company to better resonate with high-growth customer segments.

New York, Ny

Steadily progressed through roles of increased responsibility and scope in investor and analyst communications, including the areas of research, messaging, presentations, and support. Served as primary point of contact for investor inquiries and sellside analysts covering the company. Worked cross-functionally across all stakeholder groups and executive management. Developed relationships with new institutional investors and managed corporate and IR website with full ownership for posting… Show more Steadily progressed through roles of increased responsibility and scope in investor and analyst communications, including the areas of research, messaging, presentations, and support. Served as primary point of contact for investor inquiries and sellside analysts covering the company. Worked cross-functionally across all stakeholder groups and executive management. Developed relationships with new institutional investors and managed corporate and IR website with full ownership for posting timely updates and announcements. Show less

Greater New York City Area

Investor Relations Advisory Services for ADR Issuers. Assist international companies in their IR efforts in North America including strategy and best practices for Institutional and Retail IR. Specialize in Institutional Investor Targeting.

Master Of Business Administration - Mba

Bachelor Of Science, Business & Technology